Prior authorizations create substantial administrative and financial burdens on physicians and patients and can disrupt the continuity of care.

The N.C. Senate and House of Representatives differ on how to make health care more affordable and accessible, including ...

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization to RINVOQ� (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in ...

Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term ...

Pharmacovigilance evolves with technology, employing active surveillance to detect drug-related issues and ensure safety in an increasingly complex landscape.

MELBOURNE, Australia I April 02, 2025 I Telix Pharmaceuticals Limited (ASX: TLX; NASDAQ: TLX, Telix, the Company) today announces that a first patient has ...

Eisai & Biogen update on regulatory review of MAA for lecanemab for early Alzheimer’s disease by the European Commission: Tokyo Wednesday, April 2, 2025, 16:00 Hrs [IST] Eisai C ...

Investors interested in arranging a meeting with the Company’s management during the conference should contact the Jones Trading conference coordinator. A live webcast of the presentation can be found ...

Health insurance companies are under increasing scrutiny for allegedly using artificial intelligence bots and algorithms to swiftly deny patients routine or lifesaving care— without a human actually ...

Judge Sean D. Jordan of the U.S. District Court for the Eastern District of Texas ruled that the Food and Drug Administration ...

Trinity Capital Inc.  (the "Company"), a leading alternative asset manager, today announced the commitment of up to $68.75 million in growth capital to CMR Surgical, a global medical devices company ...